1. Home
  2. SES vs RCKT Comparison

SES vs RCKT Comparison

Compare SES & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SES
  • RCKT
  • Stock Information
  • Founded
  • SES 2012
  • RCKT 1999
  • Country
  • SES United States
  • RCKT United States
  • Employees
  • SES N/A
  • RCKT N/A
  • Industry
  • SES Auto Parts:O.E.M.
  • RCKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SES Consumer Discretionary
  • RCKT Health Care
  • Exchange
  • SES Nasdaq
  • RCKT Nasdaq
  • Market Cap
  • SES 384.0M
  • RCKT 328.6M
  • IPO Year
  • SES N/A
  • RCKT N/A
  • Fundamental
  • Price
  • SES $1.12
  • RCKT $3.28
  • Analyst Decision
  • SES Hold
  • RCKT Buy
  • Analyst Count
  • SES 3
  • RCKT 13
  • Target Price
  • SES $1.50
  • RCKT $12.96
  • AVG Volume (30 Days)
  • SES 5.6M
  • RCKT 6.0M
  • Earning Date
  • SES 08-04-2025
  • RCKT 08-07-2025
  • Dividend Yield
  • SES N/A
  • RCKT N/A
  • EPS Growth
  • SES N/A
  • RCKT N/A
  • EPS
  • SES N/A
  • RCKT N/A
  • Revenue
  • SES $11,360,000.00
  • RCKT N/A
  • Revenue This Year
  • SES $883.92
  • RCKT N/A
  • Revenue Next Year
  • SES $159.98
  • RCKT $108.43
  • P/E Ratio
  • SES N/A
  • RCKT N/A
  • Revenue Growth
  • SES N/A
  • RCKT N/A
  • 52 Week Low
  • SES $0.20
  • RCKT $2.19
  • 52 Week High
  • SES $2.53
  • RCKT $22.01
  • Technical
  • Relative Strength Index (RSI)
  • SES 51.03
  • RCKT 51.17
  • Support Level
  • SES $1.09
  • RCKT $2.88
  • Resistance Level
  • SES $1.22
  • RCKT $3.74
  • Average True Range (ATR)
  • SES 0.07
  • RCKT 0.27
  • MACD
  • SES -0.00
  • RCKT 0.02
  • Stochastic Oscillator
  • SES 55.32
  • RCKT 35.43

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: